The Latest Breaking News from Penumbra

Penumbra Inc (NYSE:PEN) posted Q4 FY21 revenue of $204 million, +22.2% Y/Y (up 23% in constant currency), beating the consensus of $194.30 million. Revenue from sales of vascular products grew 30.4% (31.1%) to $113.6 million.  Revenue from sales of neuro products grew 13.3% (14.1%) to $90.4 million. The gross margin was 61.5%,…

Benzinga Pro data, Penumbra (NYSE:PEN) reported Q4 sales of $204.01 million. Earnings fell to a loss of $24.63 million, resulting in a 406.72% decrease from last quarter. In Q3, Penumbra earned $8.03 million and total sales reached $190.12 million.

Penumbra (NYSE:PEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra missed estimated earnings by 54.55%, reporting an EPS of $0.1 versus an estimate of $0.22.